Skip to main content
. 2022 Mar 3;14(5):1304. doi: 10.3390/cancers14051304

Figure 3.

Figure 3

Overall survival rates (A) for patients with clinical stage I/II or III (B) for patients with or without surgery (C) for patients with 20 Gy mean left main coronary artery (LMA) dose cutoff.